SciELO - Scientific Electronic Library Online

 
vol.30 issue2Histoplasmose em pacientes imunodeprimidos: estudo de 18 casos observados em Uberlândia, MGLimiar anaeróbio detectado pela "análise da curva-V" na cardiopatia chagásica crônica author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

Share


Revista da Sociedade Brasileira de Medicina Tropical

Print version ISSN 0037-8682On-line version ISSN 1678-9849

Abstract

SAMPAIO, Raimunda Nonata Ribeiro  and  MARSDEN, Phillip Davis. Tratamento da forma mucosa de leishmaniose sem resposta a glucantime, com anfotericina B liposomal. Rev. Soc. Bras. Med. Trop. [online]. 1997, vol.30, n.2, pp.125-128. ISSN 0037-8682.  http://dx.doi.org/10.1590/S0037-86821997000200007.

We treated six patients with mucosal leishmaniasis who failed to respond to glucantime (20mg/kg/day) with ambisome (2-5 grams total dose). The daily dose was 2-3mg/kg/day given for a minimum of 20 days. After 26-38 months of follow up, five patients were clinically cured. One relapsed after six months. No side effects of therapy were observed apart from headache after injection. Ambisome is a therapeutic option for patients with mucosal leishmaniasis unresponsive to antimonials.

Keywords : Mucosal leishmaniasis; Leishmania (Viannia) braziliensis; Amphotericin B liposome.

        · abstract in Portuguese     · text in Portuguese     · Portuguese ( pdf epdf )

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License